Author Response: Skeletal Muscle and Peripheral Nerve Histopathology in COVID-19
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
We are grateful for the interest in our research.1 As mentioned in our study, hyperCKemia, myalgias, and myositis have been reported in patients with COVID-19, but it has remained unclear whether muscle damage is because of viral infection of muscle, toxic effect of cytokines, or another mechanism. Our autopsy study sought to explore that ambiguity.1 Some have postulated that skeletal muscles and nerves are susceptible to direct SARS-CoV-2 invasion, but this is not proven. We found no evidence for direct invasion of muscle or nerve in our 35 autopsies.1 This result was not necessarily due to our patients' asymptomatic presentations. We could not target symptomatic muscle or nerves because our patients were too weak to give a reliable history in this regard, with most of them on a ventilator. Furthermore, the virus was still evident in the lungs in all patients, as tested by PCR and by immunohistochemistry in 22 of the 35 patients at autopsy. It is important that another large autopsy series looking at muscle in 43 patients dying of COVID-19 found comparable features, and similarly, none had evidence of direct viral infection of muscle.2
Footnotes
Author disclosures are available upon request (journal{at}neurology.org).
- © 2021 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.